Association of the triglyceride-high-density lipoprotein-glucose-body index (TyHGB) with depression in US adults: A population-based cross-sectional study
This population-based cross-sectional study of 13,769 US adults reveals that the novel triglyceride-high-density lipoprotein-glucose-body index (TyHGB) is significantly and nonlinearly associated with depressive symptoms, exhibiting a J-shaped dose-response relationship where higher levels predict increased depression risk, thereby suggesting TyHGB as a practical, low-cost screening tool for early identification.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Depression is a heavy burden that affects hundreds of millions of people worldwide, often leaving them feeling stuck in a fog of low mood and lost interest in life. While doctors have long relied on conversations and questionnaires to diagnose it, the search for a physical clue—a biological sign that could be spotted early—has been difficult. Scientists have increasingly looked toward the body's metabolism, the complex system that turns food into energy. They know that when this system struggles, such as when the body has trouble processing sugar or managing fat, it can trigger inflammation and stress that reach the brain. One specific area of interest is a combination of high blood sugar, unhealthy cholesterol levels, and excess body weight. These factors often travel together, creating a state of metabolic strain that researchers suspect might be linked to how a person feels emotionally.
A new study published by researchers from Zhejiang University and the Zhejiang Chinese Medical University takes a closer look at this connection. The team analyzed data from nearly 14,000 adults across the United States, gathered over many years by a major national health survey. They focused on a newly developed number called the TyHGB index. This is not a complicated test requiring special equipment; it is a simple calculation based on four measurements that are already part of a standard doctor's visit: triglycerides (a type of fat in the blood), high-density lipoprotein (often called "good" cholesterol), fasting blood sugar, and body mass index. By combining these four routine numbers, the researchers created a single score that reflects the body's overall metabolic health. They wanted to see if people with higher scores on this index were more likely to report symptoms of depression.
The results revealed a clear and significant link. As the TyHGB score went up, the likelihood of experiencing depressive symptoms also increased. The study found that adults with the highest scores were 60 percent more likely to have depression compared to those with the lowest scores. This relationship held true even after the researchers accounted for other factors that could influence mood, such as age, gender, education, income, smoking, and existing health conditions like diabetes or heart disease. The findings suggest that the metabolic burden captured by this single number is an independent risk factor for depression, separate from these other common variables.
Perhaps the most intriguing discovery was the shape of this relationship. The risk did not rise in a straight, steady line. Instead, the data showed a distinct turning point. Below a certain score, the risk of depression did not increase significantly. However, once the TyHGB score crossed a specific threshold, the risk began to climb sharply. It is as if the body can handle a certain amount of metabolic stress without immediate emotional consequences, but once that limit is passed, the system tips, and the risk of depression accelerates. The researchers identified this critical tipping point at a score of 7.56. Above this number, every small increase in the score was associated with a noticeable jump in the odds of having depression.
To ensure these findings were robust, the researchers used advanced computer models to test how well the TyHGB score could predict depression compared to other methods. The models confirmed that this simple index is a powerful tool for identifying risk, performing better than many other single measurements. The study also checked if this link was different for men versus women, or for people of different ages and backgrounds, and found that the pattern remained consistent across all groups. This suggests that the connection between metabolic health and mood is a universal feature of human biology, not limited to a specific type of person.
While the study provides strong evidence of a connection, the researchers are careful to note that their work is a snapshot in time. Because they looked at data from a single period rather than following people over many years, they cannot prove that a high TyHGB score causes depression. It is possible that depression leads to lifestyle changes that worsen metabolic health, or that a third factor influences both. However, the discovery of a specific threshold offers a practical path forward. Because the TyHGB index relies on blood tests and height and weight measurements that are already done in almost every clinic, it could serve as an easy, low-cost screening tool. Doctors could use it to spot individuals who are at higher risk for depression long before severe symptoms appear, allowing for earlier support and intervention. The study concludes that understanding the body's metabolic state is a vital piece of the puzzle in understanding and treating depression, offering a new way to look at an old problem.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.